Research Facility

Birmingham, Alabama 35294

1 studies enrolling now · 8 studies all time

What they study most

Anemia, Chronic Kidney Disease, Chronic Renal Failure, Hepatocellular Carcinoma (HCC), Hypoactive Sexual Desire Disorder, Lactose Intolerance, Osteoarthritis, Ulcerative Colitis

Studies at this site

• Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC — Recruiting now
• Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance — Completed
• A Comparison of Once a Day Dose Compared to 2 Doses/Day — Completed
• A Double Blind Study for the Treatment of Acute Ulcerative Colitis — Completed
• Peginesatide for Anemia in Chronic Hemodialysis Patients — Completed
• Safety of Buprenorphine Transdermal Patch (BTDS) in Osteoarthritis Pain: a 52-Week Extension Phase — Stopped early
• Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents With Active Ulcerative Colitis — Completed
• Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women — Completed